From synapse to nucleus: novel targets for treating depression.

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• Depression poses significant societal and financial burdens, necessitating novel therapeutic strategies.
• Existing treatments for depression have limitations, driving the search for new compounds.
• Understanding biological mechanisms underlying depression and resilience is crucial for treatment development.

Purpose of the Study:

• To review potential molecular systems and protein targets implicated in depression and resilience.
• To identify promising targets for future preclinical and clinical investigations.
• To explore the role of neurotrophic factors, glutamate receptors, and other systems in depressive disorders.

Main Methods:

• Literature review of preclinical and clinical studies on depression and resilience.
• Analysis of candidate molecular systems including neurotrophic factors, glutamate receptors, hypothalamic feeding peptides, nuclear hormone receptors, and epigenetic mechanisms.
• Examination of protein targets associated with these systems.

Main Results:

• Neurotrophic factors, glutamate receptors, hypothalamic feeding peptides, nuclear hormone receptors, and epigenetic mechanisms show promise as targets.
• Preclinical models provide evidence for the involvement of these systems in depressive behavior and resilience.
• Several molecular systems are identified as interesting targets for future research.

Conclusions:

• Targeting specific molecular systems offers a promising avenue for developing novel depression treatments.
• Further research into selective compounds for these targets is warranted.
• Advancing the understanding of depression's molecular underpinnings may lead to improved therapeutic outcomes.